| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6245789 | Journal of Vascular and Interventional Radiology | 2015 | 8 Pages |
Abstract
RE offers a safe and effective treatment for patients with GIST liver metastases who do not show a response to TKIs. RE could be an option for earlier phases of therapy in patients with mutational status. The results might also challenge the notion that GISTs are resistant to radiation therapy.
Keywords
CNRPlatelet-derived growth factor receptor AProgression-free intervalTKIPFIRadioembolizationPDGFRAstable diseaseprogressive diseaseGastrointestinal stromal tumorpositron-emission tomographySUVGiststandardized uptake valueTyrosine kinase inhibitorContrast-to-noise ratioPartial responsecomplete responsePET
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Nils MD, Steffen J. MD, Dietmar MD, Jochen MD, Daniel MD, Stefan O. MD, Peter MD,